Dr Suzanne Freeman

Research Associate

CONTACT DETAILS

Department of Health Sciences
University of Leicester
Centre for Medicine
University Road
Leicester LE1 7RH

Tel: 00 44 116 252 3216

Email:   suzanne.freeman@leicester.ac.uk

 

Personal Details

I am a research associate in the biostatistics methods group and part of the NIHR Complex Reviews Support Unit. As part of the CRSU I support NIHR-funded researchers with their evidence synthesis problems.

 

Research

My main research areas are:

  • Network meta-analysis
  • Individual participant data meta-analysis
  • Synthesis of time-to-event data

 

Publications

Freeman SC, Carpenter JR. Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models. Research Synthesis Methods 2017; 1-15.
https://doi.org/10.1002/jrsm.1253

Fisher D, Carpenter J, Morris T, Freeman SC, Tierney J. Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach? BMJ 2017; 356; j573

Freeman S, Carpenter J, Tierney J. One-Step Individual Patient Data (IPD) Network Meta-Analysis of Survival Data using Royston-Parmar Models. Trials 2015: 16(Suppl 2):P161

Langley RE, Cafferty FH, Alhasso AA, Rosen SD, Sundaram SK, Freeman SC, Pollock P et al. Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09). The Lancet Oncology 2013; 14(4):306

Cafferty FH, Gabe R, Huddart RA, Rustin G, Williams MP, Stenning SP, Bara A, Bathia R, Freeman SC, Alder L, Joffe JK. UK Management Practices in Stage I Seminoma and the Medical Research Council Trial of Imaging and Schedule in Seminoma Testis Managed with Surveillance. Clinical Oncology 2012; 24: 25

Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self-monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011; 343: d3805

Conference Abstracts & Workshops

Freeman SC, Scott NW, Powell R, Johnston M, Sutton AJ, Cooper NJ. Network meta-analysis of complex interventions: accounting for component effects and control group risk. Oral presentation. Global Evidence Summit, Cape Town 2017

Hawkins N, Latimer N, Freeman S, Woods B. Survival analysis: beyond proportional hazards. Invited session. Royal Statistical Society Conference, Glasgow, 2017

Powell R, Freeman S, Scott NW, Sutton A, Cooper N, Manyande A, Vögele C, Bruce J, Byrne-Davis L, Johnston M. Understanding the contribution of intervention components: A component-based network meta-analysis approach to psychological preparation for surgery. European Health Psychology Society, Padova 2017

Freeman S, Fisher D, Tierney J, Carpenter J. A framework for identifying treatment-covariate interactions in individual participant data network meta-analysis. Oral presentation. 4th International Clinical Trials Methodology Conference & 38th Society for Clinical Trials Meeting, Liverpool 2017

Freeman S, Fisher D, Carpenter J, White I. Inconsistency in network meta-analysis: A critical comparison of methods. Oral presentation. International Society Clinical Biostatistics, Birmingham 2016

Freeman S, Carpenter J, Tierney J. One-Step Individual Patient Data (IPD) Network Meta-Analysis of Survival Data using Royston-Parmar Models. Poster presentation. International Clinical Trials Methodology Conference, Glasgow 2015

Hook J, Freeman S, Stenning S, McNeish I, Perren T, Naik R, Kaye S, Ledermann J, Clamp A. GCIG ICON8 trial stage IA analysis: safety and feasibility of two dose-fractionated weekly carboplatin-paclitaxel regimens for the first-line treatment of ovarian cancer. European Society of Gynaecological Oncology 2013

Hook J, Freeman S, Stenning S, Petrie J, McNeish I, Perren T, Naik R, Kaye S, Ledermann J, Clamp A. ICON8 trial stage IA analysis: safety and feasibility of two dose-fractionated weekly carboplatin-paclitaxel regimens for first-line treatment of ovarian cancer. NCRI Cancer Conference 2013

Hook J, Freeman S, Tomiczek M, Stenning S, McNeish I, Ledermann J, Clamp A. Current delays in setting-up investigator-driven randomised controlled trials: the ICON8 experience. NCRI Cancer Conference 2012

Abel PD, Sundaram SK, Godsland IF, Kynaston HG, Clarke NW, Alhasso AA, Rosen SD, Freeman SC, Jinks RC, Pollock P, Cafferty FH, Parmar M, Langley RE. Cardiovascular events and metabolic changes in prostate cancer patients treated with transcutaneous oestrogen patches compared with LHRH analogues: Results from a randomized phase II trial (MRC PR09 PATCH). The Prostate Cancer Charity National Research Conference 2011

Share this page: